Document ID: chunk:federal_register_of_legislation:F2024C01066:reg:9
Version: federal_register_of_legislation:F2024C01066
Segment Type: reg
Provision Reference: reg 9
Character Range: 24576–26034

9  Information about supplies
 (1) For the purposes of paragraphs 98AC(4)(a) and 99AAA(8)(b) of the Act, subsection (2) specifies the information that is to be given to the Secretary by an approved supplier in relation to the supply by the approved supplier of a pharmaceutical benefit.
 (2) The information is the following:
 (a) the approved supplier's approval number allotted under section 16 of the Regulations;
 (b) if the approval number is to be given using the manual system and the approved supplier is an approved pharmacist:
 (i) the pharmacist's name; and
 (ii) the address of the premises to which the approval number relates;
 (c) if the approval number is to be given using the manual system and the approved supplier is an approved medical practitioner:
 (i) the medical practitioner's name; and
 (ii) the address to which the medical practitioner wishes correspondence to be sent;
 (d) if the approval number is to be given using the manual system and the approved supplier is an approved hospital authority:
 (i) the approved hospital authority's name; and
 (ii) the address of the hospital to which the approval number relates;
 (e) if the approval number is to be given using the Claims Transmission System—the information required under Schedule 1 to be given in relation to the supply of the pharmaceutical benefit.
Note: The information must be given to the Chief Executive Medicare on behalf of the Secretary (see subsection 8(2)).